Literature DB >> 27703159

Synthesis and structure-activity relationships of novel lincomycin derivatives part 3: discovery of the 4-(pyrimidin-5-yl)phenyl group in synthesis of 7(S)-thiolincomycin analogs.

Yoshinari Wakiyama1, Ko Kumura1, Eijiro Umemura1, Satomi Masaki1, Kazutaka Ueda1, Yasuo Sato1, Takashi Watanabe1, Yoko Hirai1, Keiichi Ajito1.   

Abstract

Novel lincomycin derivatives possessing an aryl phenyl group or a heteroaryl phenyl group at the C-7 position via sulfur atom were synthesized by Pd-catalyzed cross-coupling reactions of 7(S)-7-deoxy-7-thiolincomycin (5) with various aryl halides. This reaction is the most useful method to synthesize a variety of 7(S)-7-deoxy-7-thiolincomycin derivatives. On the basis of analysis of structure-activity relationships of these novel lincomycin derivatives, we found that (a) the location of basicity in the C-7 side chain was an important factor to enhance antibacterial activities, and (b) compounds 22, 36, 42, 43 and 44 had potent antibacterial activities against a variety of Streptococcus pneumoniae with erm gene, which cause severe respiratory infections, even compared with our C-7-modified lincomycin analogs (1-4) reported previously. Furthermore, 7(S)-configuration was found to be necessary for enhancing antibacterial activities from comparison of configurations at the 7-position of 36 (S-configuration) and 41 (R-configuration).

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27703159     DOI: 10.1038/ja.2016.114

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  27 in total

1.  The FDA and the case of Ketek.

Authors:  David B Ross
Journal:  N Engl J Med       Date:  2007-04-19       Impact factor: 91.245

2.  Synthesis and antibacterial activity of novel lincomycin derivatives. I. Enhancement of antibacterial activities by introduction of substituted azetidines.

Authors:  Ko Kumura; Yoshinari Wakiyama; Kazutaka Ueda; Eijiro Umemura; Takashi Watanabe; Eiki Shitara; Hideki Fushimi; Takuji Yoshida; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2016-01-13       Impact factor: 2.649

3.  Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms.

Authors:  J Retsema; A Girard; W Schelkly; M Manousos; M Anderson; G Bright; R Borovoy; L Brennan; R Mason
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

4.  Molecular characterization of the first telithromycin-resistant Streptococcus pneumoniae isolate in Germany.

Authors:  Ralf René Reinert; Mark van der Linden; Adnan Al-Lahham
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

5.  Chemical modification of lincomycin.

Authors:  B J Magerlein; R D Birkenmeyer; F Kagan
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1966

6.  Synthesis and antibacterial activity of HMR 3647 a new ketolide highly potent against erythromycin-resistant and susceptible pathogens.

Authors:  A Denis; C Agouridas; J M Auger; Y Benedetti; A Bonnefoy; F Bretin; J F Chantot; A Dussarat; C Fromentin; S G D'Ambrières; S Lachaud; P Laurin; O Le Martret; V Loyau; N Tessot; J M Pejac; S Perron
Journal:  Bioorg Med Chem Lett       Date:  1999-11-01       Impact factor: 2.823

7.  Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance.

Authors:  Daqi Tu; Gregor Blaha; Peter B Moore; Thomas A Steitz
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

8.  Lincomycin. X. The chemical synthesis of lincomycin.

Authors:  B J Magerlein
Journal:  Tetrahedron Lett       Date:  1970-01       Impact factor: 2.415

9.  Telithromycin: the perils of hasty adoption and persistence of off-label prescribing.

Authors:  Patrick P Gleason; Carol Walters; Alan H Heaton; Jeremy A Schafer
Journal:  J Manag Care Pharm       Date:  2007-06

10.  A general palladium-catalyzed coupling of aryl bromides/triflates and thiols.

Authors:  Takahiro Itoh; Toshiaki Mase
Journal:  Org Lett       Date:  2004-11-25       Impact factor: 6.005

View more
  3 in total

1.  Synthesis and SARs of novel lincomycin derivatives Part 5: optimization of lincomycin analogs exhibiting potent antibacterial activities by chemical modification at the 6- and 7-positions.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Satomi Masaki; Kazutaka Ueda; Yasuo Sato; Yoko Hirai; Yoshio Hayashi; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-11-01       Impact factor: 2.649

2.  Synthesis and structure-activity relationships of novel lincomycin derivatives. Part 4: synthesis of novel lincomycin analogs modified at the 6- and 7-positions and their potent antibacterial activities.

Authors:  Yoshinari Wakiyama; Ko Kumura; Eijiro Umemura; Kazutaka Ueda; Takashi Watanabe; Keiko Yamada; Takafumi Okutomi; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-05-31       Impact factor: 2.649

3.  Synthesis and antibacterial activity of novel lincomycin derivatives. IV. Optimization of an N-6 substituent.

Authors:  Ko Kumura; Yoshinari Wakiyama; Kazutaka Ueda; Eijiro Umemura; Yoko Hirai; Keiko Yamada; Keiichi Ajito
Journal:  J Antibiot (Tokyo)       Date:  2017-11-08       Impact factor: 2.649

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.